169 related articles for article (PubMed ID: 9403048)
1. Can positron emission tomography distinguish tumor recurrence from irradiation sequelae in patients treated for larynx cancer?
Greven KM; Williams DW; Keyes JW; McGuirt WF; Watson NE; Case LD
Cancer J Sci Am; 1997; 3(6):353-7. PubMed ID: 9403048
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer.
Greven KM; Williams DW; Keyes JW; McGuirt WF; Harkness BA; Watson NE; Raben M; Frazier LC; Geisinger KR; Cappellari JO
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):841-5. PubMed ID: 8040032
[TBL] [Abstract][Full Text] [Related]
3. F-18 FDG PET scan after radiotherapy for early-stage larynx cancer.
Kim HJ; Boyd J; Dunphy F; Lowe V
Clin Nucl Med; 1998 Nov; 23(11):750-2. PubMed ID: 9814562
[TBL] [Abstract][Full Text] [Related]
4. Improved detection of recurrent laryngeal tumor after radiotherapy using (18)FDG-PET as initial method.
Brouwer J; de Bree R; Comans EF; Akarriou M; Langendijk JA; Castelijns JA; Hoekstra OS; Leemans CR
Radiother Oncol; 2008 May; 87(2):217-20. PubMed ID: 18329117
[TBL] [Abstract][Full Text] [Related]
5. F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/ pharyngeal cancer.
Terhaard CH; Bongers V; van Rijk PP; Hordijk GJ
Head Neck; 2001 Nov; 23(11):933-41. PubMed ID: 11754496
[TBL] [Abstract][Full Text] [Related]
6. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography.
Stokkel MP; Terhaard CH; Hordijk GJ; van Rijk PP
Eur J Nucl Med; 1999 Jul; 26(7):767-73. PubMed ID: 10398825
[TBL] [Abstract][Full Text] [Related]
7. Clinical Utility of Pretreatment and 3-Month
Mayo Z; Seyedin SN; Mallak N; Mott SL; Menda Y; Graham M; Anderson C
Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):595-600. PubMed ID: 30808209
[TBL] [Abstract][Full Text] [Related]
8. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings.
Frank A; Lefkowitz D; Jaeger S; Gobar L; Sunderland J; Gupta N; Scott W; Mailliard J; Lynch H; Bishop J
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1495-512. PubMed ID: 7635795
[TBL] [Abstract][Full Text] [Related]
9. Early recurrence or submucosal residual of laryngeal squamous cell carcinoma: diagnosis by CT-guided endolaryngeal core biopsy on a transcutaneous approach.
Rousset J; Abgral R; Chinellato S; Garetier M; Barberot C; Valette G; Potard G; Le Bivic T; Salaun PY
Head Neck; 2013 Jul; 35(7):E202-4. PubMed ID: 22619005
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
Kahn D; Follett KA; Bushnell DL; Nathan MA; Piper JG; Madsen M; Kirchner PT
AJR Am J Roentgenol; 1994 Dec; 163(6):1459-65. PubMed ID: 7992747
[TBL] [Abstract][Full Text] [Related]
11. Therapy evaluation of laryngeal carcinomas by tyrosine-pet.
De Boer JR; Pruim J; Burlage F; Krikke A; Tiebosch AT; Albers FW; Vaalburg W; Van Der Laan BF
Head Neck; 2003 Aug; 25(8):634-44. PubMed ID: 12884346
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis with (18)F-FDG PET scan after larynx preservation by primary radiochemotherapy].
Dietz A; Rudat V; Harms W; Jungehülsing M; Dollner R; Henze M
HNO; 2004 Jan; 52(1):38-44. PubMed ID: 14740113
[TBL] [Abstract][Full Text] [Related]
13. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy.
Chaiken L; Rege S; Hoh C; Choi Y; Jabour B; Juillard G; Hawkins R; Parker R
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):455-64. PubMed ID: 8407422
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of an (18)F-FDG-PET based strategy to optimize the diagnostic trajectory of suspected recurrent laryngeal carcinoma after radiotherapy: The RELAPS multicenter randomized trial.
de Bree R; van der Putten L; van Tinteren H; Wedman J; Oyen WJ; Janssen LM; van den Brekel MW; Comans EF; Pruim J; Takes RP; Hobbelink MG; Valdés Olmos R; van der Laan BF; Boers M; Hoekstra OS; Leemans CR
Radiother Oncol; 2016 Feb; 118(2):251-6. PubMed ID: 26477395
[TBL] [Abstract][Full Text] [Related]
16. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
[TBL] [Abstract][Full Text] [Related]
17. Primary and recurrent early stage laryngeal cancer: preliminary results of 2-[fluorine 18]fluoro-2-deoxy-D-glucose PET imaging.
Lowe VJ; Kim H; Boyd JH; Eisenbeis JF; Dunphy FR; Fletcher JW
Radiology; 1999 Sep; 212(3):799-802. PubMed ID: 10478249
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography in the detection of residual laryngeal carcinoma.
Austin JR; Wong FC; Kim EE
Otolaryngol Head Neck Surg; 1995 Oct; 113(4):404-7. PubMed ID: 7567012
[TBL] [Abstract][Full Text] [Related]
19. Comparison of physical examination and fluorodeoxyglucose positron emission tomography/computed tomography 4-6 months after radiotherapy to assess residual head-and-neck cancer.
Zundel MT; Michel MA; Schultz CJ; Maheshwari M; Wong SJ; Campbell BH; Massey BL; Blumin J; Wilson JF; Wang D
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e825-32. PubMed ID: 21300450
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
